Literature DB >> 8773517

A phase I study of an adeno-associated virus-CFTR gene vector in adult CF patients with mild lung disease.

T Flotte, B Carter, C Conrad, W Guggino, T Reynolds, B Rosenstein, G Taylor, S Walden, R Wetzel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8773517     DOI： 10.1089/hum.1996.7.9-1145

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN： 1043-0342            Impact factor:   5.695


× No keyword cloud information.
  75 in total

1.  Bad for cats, good for humans? Modified feline immunodeficiency virus for gene therapy.

Authors:  R G Crystal
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

Review 2.  Designing antisense to inhibit the renin-angiotensin system.

Authors:  D Mohuczy; M I Phillips
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

Review 3.  Adenoassociated virus vectors for genetic immunization.

Authors:  Selvarangan Ponnazhagan
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 4.  Virus-based gene delivery systems.

Authors:  Cathryn Mah; Barry J Byrne; Terence R Flotte
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 5.  Gene therapy in clinical medicine.

Authors:  S M Selkirk
Journal:  Postgrad Med J       Date:  2004-10       Impact factor: 2.401

Review 6.  Cell and gene therapy for genetic diseases: inherited disorders affecting the lung and those mimicking sudden infant death syndrome.

Authors:  Allison M Keeler; Terence R Flotte
Journal:  Hum Gene Ther       Date:  2012-06       Impact factor: 5.695

7.  High-efficiency transduction of fibroblasts and mesenchymal stem cells by tyrosine-mutant AAV2 vectors for their potential use in cellular therapy.

Authors:  Mengxin Li; Giridhara R Jayandharan; Baozheng Li; Chen Ling; Wenqin Ma; Arun Srivastava; Li Zhong
Journal:  Hum Gene Ther       Date:  2010-10-06       Impact factor: 5.695

Review 8.  Adeno-associated virus vectors: potential applications for cancer gene therapy.

Authors:  Chengwen Li; Dawn E Bowles; Terry van Dyke; Richard Jude Samulski
Journal:  Cancer Gene Ther       Date:  2005-12       Impact factor: 5.987

9.  Birth of a new therapeutic platform: 47 years of adeno-associated virus biology from virus discovery to licensed gene therapy.

Authors:  Terence R Flotte
Journal:  Mol Ther       Date:  2013-11       Impact factor: 11.454

Review 10.  Gene therapy using adeno-associated virus vectors.

Authors:  Shyam Daya; Kenneth I Berns
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.